Declan Doogan, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 2,078 shares at $45.51 ($95K) on 2019-02-19, disclosed to the SEC on 2019-02-20.
Open-market sale of $95k BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.42 | 678 | $31K | 32.6% |
| 2 | $45.51 | 1,400 | $64K | 67.4% |
| Total | $45.48 avg | 2,078 | $95K | 100% |
| Filing → |
| BHVN | SELL | 2022-02-11 | $5.0M | — | Filing → |
| BHVN | SELL | 2021-12-01 | $5.5M | — | Filing → |
| BHVN | SELL | 2021-11-17 | $8.8M | — | Filing → |